RATES Act

The RATES Act, also known as Bill 117 hr 7204, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to address the issue of rising prescription drug prices by requiring pharmaceutical companies to justify any price increases for certain medications.

Under the RATES Act, pharmaceutical companies would be required to provide a detailed explanation for any price increase that exceeds the rate of inflation. This information would need to be submitted to the Department of Health and Human Services, as well as made publicly available on the company's website.

Additionally, the bill would establish a new Office of Drug Pricing within the Department of Health and Human Services to monitor and enforce compliance with the new requirements. This office would also be responsible for conducting regular audits of pharmaceutical companies to ensure they are following the rules. Overall, the RATES Act aims to increase transparency in the pharmaceutical industry and hold companies accountable for their pricing practices. By requiring companies to justify price increases and making this information accessible to the public, the bill seeks to help lower prescription drug costs for consumers.